The broad recognition specificity exhibited by integrin α M β 2 (Mac-1, CD11b/CD18) has allowed this adhesion receptor to play innumerable roles in leukocyte biology, yet we know little about how and why α M β 2 binds its multiple ligands. Within α M β 2 , the α M I-domain is responsible for integrin's multiligand binding properties. To identify its recognition motif, we screened peptide libraries spanning sequences of many known protein ligands for α M I-domain binding and also selected the α M I-domain recognition sequences by phage display. Analyses of >1400 binding and nonbinding peptides derived from peptide libraries showed that a key feature of the α M I-domain recognition motif is a small core consisting of basic amino acids flanked by hydrophobic residues. Furthermore, the peptides selected by phage display conformed to a similar pattern. Identification of the recognition motif allowed the construction of an algorithm that reliably predicts the α M Idomain binding sites in the α M β 2 ligands. The recognition specificity of the α M I-domain resembles that of some chaperones, which allows it to bind segments exposed in unfolded proteins. The disclosure of the α M β 2 binding preferences allowed the prediction that cationic host defense peptides, which are strikingly enriched in the α M I-domain recognition motifs, represent a new class of α M β 2 ligands. This prediction has been tested by examining the interaction of α M β 2 with the human cathelicidin peptide LL-37. LL-37 induced a potent α M β 2 -dependent cell migratory response and caused activation of α M β 2 on neutrophils. The newly revealed recognition specificity of α M β 2 toward unfolded protein segments and cationic proteins and peptides suggests that α M β 2 may serve as a previously proposed "alarmin" receptor with important roles in innate host defense. 
Integrins are noncovalently associated α-β heterodimer receptors that mediate adhesive interactions of cells with the extracellular matrix and other cells. Integrins regulate a diverse range of processes, including cell migration, differentiation, the immune response, and maintenance of tissue architecture. Many integrins exhibit a very broad ligand binding specificity and can bind various proteins that share no obvious sequence similarity. Furthermore, even integrins that selectively recognize the RGD adhesion motif are capable of binding numerous ligands that lack this sequence and belong to diverse protein families. To date, the mechanisms underlying the broad ligand specificity exhibited by integrins remain unknown.
α M β 2 (Mac-1, CD11b/CD18), which belongs to the β 2 subfamily of leukocyte integrins, is the most promiscuous integrin with more than 40 reported protein ligands. α M β 2 is expressed predominantly on myeloid cells and mediates adhesive reactions of leukocytes during the inflammatory response. In particular, it contributes to firm adhesion of neutrophils to endothelial cells, promotes their diapedesis, and participates in migration of neutrophils to sites of inflammation. [1] [2] [3] Many other neutrophil and monocyte/macrophage responses, including phagocytosis, homotypic aggregation, degranulation, and adherence to microorganisms, also depend on α M β 2 . The complexity of α M β 2 -mediated functions is believed to arise from its ability to recognize a multitude of structurally and functionally dissimilar ligands. The reported α M β 2 ligands include numerous proteins that constitute the extracellular matrix and many that become associated with the ECM during the inflammatory response (a partial list is provided in refs 4 and 5). It also binds several cellular receptors such as ICAM-1, GPIbα, and JAM-3. [6] [7] [8] Further adding to the diversity, several proteases, such as elastase, myeloperoxidase, and plasminogen, [9] [10] [11] and even the non-mammalian proteins ovalbumin and keyhole limpet hemocyanin, are α M β 2 ligands.
Each year, new and structurally unrelated proteins are being added to this already impressive list. Particularly notable additions are CD40L, which may contribute to the pathogenesis of atherosclerosis, 12 and HMGB1 (high-mobility group box 1, amphoterin), 13 a nuclear protein that is released from necrotic cells and activated macrophages and recently emerged as a potent inflammatory mediator. [14] [15] [16] The mechanism by which this single integrin can recognize such a vast repertoire of structurally unrelated proteins, the biological significance of α M β 2 's broad specificity, and the physiological relevance of many identified ligands remain poorly understood.
The approximately 200-residue α M I-domain within α M β 2 mediates ligand binding 17, 18 and is therefore responsible for the receptor's broad substrate specificity. Accordingly, binding sites for several ligands, including C3bi, fibrinogen, neutrophil inhibitory factor (NIF), and CCN1 (Cyr61), have been localized to the α M I-domain. [19] [20] [21] [22] Earlier studies have identified peptides derived from several proteins that bind the α M I-domain, including the fibrinogen peptides 190 GWTVFQKRLDGS 202 (P1), 377 YSMKKTTMKIIPFNRLTIG 395 (P2), and CCN1-derived 305 SSVKKYRPKYCGS 317 , [23] [24] [25] as putative binding sites for α M β 2 . The α M I-domain binding peptides directly support cell adhesion, inhibit α M β 2 -mediated cell adhesion, and are able to promote cell migration. [24] [25] [26] In addition to these sequences, the α M I-domain can bind other sequences in fibrinogen and CCN1, consistent with the existence of multiple binding sites for α M β 2 in these molecules. 27 The α M I-domain recognition sequences derived from fibrinogen and other α M β 2 ligands do not contain a particular consensus motif similar to RGD and have no apparent sequence homology. However, the fact that all these peptides bind the α M I-domain and support α M β 2 -mediated adhesion responses implies they contain a similar recognition signal. To identify this recognition signal, we previously used cellulose-bound peptide libraries to analyze a set of α M I-domain binding sequences derived from the γC and βC domains of fibrinogen. 27 This approach was widely utilized to define the mechanisms of recognition in biological systems in which promiscuity in ligand binding plays an important role, including molecular chaperones. [28] [29] [30] We demonstrated that the α M I-domain binds short sequences enriched in basic and hydrophobic residues. 27 However, although these analyses provided useful insights into the α M β 2 ligand binding preferences, the limited data set was not sufficient to determine the α M I-domain recognition motif.
To improve our understanding of the principles that govern the multiligand binding properties of α M β 2 , we have screened peptide libraries representing complete sequences of many known and predicted α M β 2 ligands for α M I-domain binding and selected recognition sequences by phage display. Analyses of a large data set allowed the identification of the α M I-domain recognition motif, which satisfactorily explained previous findings and led to important insights into functional consequences of α M β 2 recognition specificity.
IB4 directed against human α M and β 2 integrin subunits, respectively, were purified from conditioned media of hybridoma cells obtained from American Tissue Culture Collection (Manassas, VA) using protein A agarose. mAb CBRM1/5 conjugated to Alexa 488 was from Santa Cruz Biotechnology (Dallas, TX).
Synthesis and Screening of Peptide Libraries for α M I-Domain Binding
Peptide libraries representing the compete sequences of 15 proteins and eight antimicrobial peptides (Table 1) were prepared by parallel spot synthesis using cellulose membranes as described previously. 32 Protein amino acid sequences were obtained from the NCBI database using the corresponding accession numbers ( Table 1 ). The peptide libraries of the γC and βC domains of fibrinogen were described previously. 27 The libraries were synthesized as 9-mer overlapping peptides with a three-amino acid offset. Peptides were Cterminally attached to the cellulose via a (β-Ala) 2 spacer and were acetylated N-terminally. The membrane-bound peptides were tested for the ability to bind the α M I-domain essentially as described previously. 27 In brief, membranes were blocked with 1% BSA and incubated with 5 μg/mL 125 I-labeled α M I-domain in TBS containing 1 mM MgCl 2 , 0.1% BSA, and 2 mM dithiothreitol. Membranes were washed with TBS containing 0.05% Tween 20 and dried, and α M I-domain binding was visualized by autoradiography and analyzed by densitometry.
Determination of Energy Contributions of Amino Acids for α M I-Domain Binding and Establishment of the α M I Binding Algorithm
The algorithm predicting the α M I-domain binding sequences was constructed on the basis of the statistical energy contributions of individual amino acids within the 9-mer α M I-domain binding peptides using the strategy described previously for members of the Hsp70 family of molecular chaperones. 28 The energy values were calculated according to the equation ΔG K = -RT ln P b /P n , where R is the gas constant (8.31 J mol −1 K −1 ), T is the absolute temperature in kelvin, and P b and P n are the relative frequencies with which each amino acid occurs in binding and nonbinding peptides, respectively. Because no specific distance pattern of residues within the α M I-domain binding peptides was apparent, the relative importance of each residue within the 9-mer was assumed to be equal. The combined energy value for binding and nonbinding peptides was calculated using the computer program IRMA (available upon request), which detects potential α M I-domain binding sites contained within protein primary sequences by searching for segments with the lowest ΔG K values.
Phage Display
The phage epitope library that displays random seven-residue insertions near the N-terminus of the pIII surface protein was purchased from New England Biolabs (Ipswich, MA). The library had a complexity in excess of 2 billion independent clones. Affinity panning was performed according to the manufacturer's protocol. Briefly, the wells of 24-well plates were coated with the α M I-domain (20 μg/mL in PBS) for 3 h at 37 °C and postcoated with 1% PVA in PBS for 1 h at 22 °C. The wells were incubated with the phage library overnight at 4 °C. Following extensive washes with PBS containing 0.1% Tween 20, the α M I-domain-expanded and after the second panning were eluted with 20 μg/mL P2-C peptide. After the third panning, the phages were eluted with P2-C and the sequences of the inset were determined. Control isolations were performed using PVA. Twenty-six selected and 10 unselected phages from the PVA control were sequenced.
Solid-Phase Binding Assays
Selected peptides derived from different protein sequences were tested for their ability to compete with binding of the α M I-domain to immobilized D fragment; 96-well Immulon 4HBX microtiter plates were coated with 1 μg/mL D fragment for 3 h at 37 °C and postcoated with 1% BSA for 1 h. The α M I-domain as a fusion with GST (10 μg/mL) in TBS containing 1 mM MgCl 2 and 0.05% Tween 20 was preincubated with different concentrations of peptides for 1 h at 22 °C, and 0.1 mL aliquots were added to the wells. After incubation for 1.5 h at 37 °C, the wells were washed and anti-GST mAb (1:5000 dilution) was added. The bound α M I-domain was quantified after reaction with goat antimouse IgG conjugated with alkaline phosphatase.
Leukocyte Migration Assays
Chemotaxis assays of U937 monocytic cells were performed on 22 mm × 22 mm coverslips. Agarose (1%; Life Technologies, Carlsbad, CA) was dissolved in Hank's balanced salt solution and mixed with 2 mg/mL LL-37, which produced a final concentration of 15 μg/mL. A 10 μL drop of warm agarose solution containing LL-37 was placed at one corner of the cover glass ~1.5 mm from the edge. A control agarose drop was placed in the diagonally opposite corner of the coverslip, and the agarose was allowed to polymerize for 5 min. The coverslips were placed into wells of a six-well plate containing 5 mL of RPMI 1640 and 10% FBS. A 10 μL aliquot containing 5 × 10 4 U937 cells was loaded in the center of the cover glass, and the plate was incubated for 2 h at 37 °C in a humidified atmosphere containing 5% CO 2 . In this experimental format, the cells sediment approximately 5 min after being loaded to form an ~4-6 mm circle and begin to migrate toward the agarose drop containing LL-37. Photographs of cell migration were taken at 2 mm intervals.
In the second format, migration assays were performed with α M β 2 -expressing HEK293 cells using Transwell inserts (5 μm pore size) as previously described. 26, 33 Briefly, the upper chamber of the Transwell system contained 3 × 10 5 cells and the lower chamber LL-37 (0.1-2 μg/mL). For inhibition experiments, cells were pretreated for 15 min with 20 μg/mL anti-α M mAb 44a, anti-β 2 mAb IB4, or noninhibitory mAb OKM1. After incubation for 16 h at 37 °C, cells that adhered to the underside of the filter were fixed with paraformaldehyde and stained with Hematoxylin. Selected Transwell assays were performed with thioglycolate-elicited monocyte/macrophages isolated from the peritoneum of wild-type and α M β 2 -deficient mice (The Jackson Laboratory, Bar Harbor, ME). Macrophages were purified using the EasySep Mouse selection kit (StemCell Technologies) with mAb against F4/80 conjugated to PE and allowed to migrate for 90 min.
Cell Adhesion Assays
Adhesion assays with α M β 2 -expressing HEK293 and U937 monocytoid cells were performed essentially as described previously. 24, 34 Briefly, the wells of polystyrene 
RESULTS

Screening Peptide Libraries for α M I-Domain Binding
To determine the recognition specificity of α M β 2 , we screened cellulose-bound peptide libraries representing the complete sequences of 15 proteins for α M I-domain binding (Table  1) . These proteins were selected because they are known α M β 2 ligands (γC and βC domains of fibrinogen, CCN1, N-terminal Pg peptide, ICAM-1, myeloperoxidase, elastase, azurocidin, and soybean trypsin inhibitor) or because they are predicted to be candidate ligands on the basis of the knowledge of their amino acid sequences and physicochemical properties (cathepsin G, proteinase 3, and protein C). Indeed, cathepsin G and protein C support strong adhesion of α M β 2 -expressing HEK293 cells and monocytoid U937 cells (unpublished data). In addition, bone sialoprotein (BSP) and ovomucoid were selected as predicted nonbinding proteins. Figure 1A shows representative peptide scans derived from the α M β 2 binding and predicted nonbinding proteins. The peptide libraries were composed of 9-mer peptides that overlap by six residues. Because 6-mer peptides present minimal α M I-domain binding signals, 34 the scans contain all potential linear binding sites for the α M I-domain. The use of this screening approach is validated by previous findings that P1
(γ190-202) and P2 (γ377-395), recognition peptides derived from fibrinogen, 27 and CCN1-H2 (305-317), the recognition peptide from CCN1, 25 bound the α M I-domain when covalently coupled to the cellulose membrane ( Figure 1A ). Furthermore, the specificity of interactions is confirmed by inhibition of the α M I-domain binding to the γC library in the presence of soluble P2 peptide, 27 and the lack of binding of radiolabeled α L I domain to the γC and other peptide libraries.
The α M I-domain bound to only a subset of peptides in each library, thus providing an internal control for specificity ( Figure 1A ). α M I-domain binding peptides were present in all libraries tested, with no obvious pattern in their distribution within the scans. However, the Figure 1A ). On the basis of their ability to bind the α M I-domain, as assessed by densitometry and visual inspection, the peptides were grouped into three populations: strong binders (196), good binders (462), and nonbinding (748).
Distribution of Amino Acids within the α M I-Domain Binding Peptides
We analyzed the relative occurrence of the 20 amino acids in 1406 peptides representing the entire library. The distribution of amino acids within the library was similar to that found in natural proteins (Figure 2A ), except that Ala and Lys were less frequent (~1.4-fold) and Arg was more frequent (1.4-fold). The higher frequency of occurrence of Arg probably reflects the fact that established α M β 2 ligands such as elastase, myeloperoxidase, and azurocidin and the predicted ligand cathepsin G are cationic proteins that are unusually enriched with this amino acid. The distribution of amino acids in the α M I-domain binding and nonbinding peptides deviated substantially from that in the total library. As shown in Figure 2B , peptides that bind the α M I-domain strongly were enriched with basic residues Arg and Lys (~2-2.5-fold) and somewhat enriched with the large hydrophobic residues Leu, Ile, Phe, Val, and Met (~1.1-1.5-fold). While the increase in each hydrophobic residue was small, the combined enrichment was ~2-fold ( Figure S1A of the Supporting Information). Negatively charged residues were strongly disfavored, and polar residues His, Asn, Gln, and Cys were depleted (~2.7-fold) ( Figure 2B and Figure S1A of the Supporting Information). A similar trend existed in the population of good binders; basic residues were over-represented up to ~1.4-fold, whereas hydrophobic residues were enriched to the same degree as in strong binders (not shown). In contrast, nonbinding peptides were enriched in negatively charged and polar amino acids ( Figure 2C and Figure S1B of the Supporting Information), whereas basic residues were strongly disfavored and hydrophobic residues slightly disfavored. Furthermore, Tyr was enriched in strong ( Figure 2B ) but not in nonbinding peptides ( Figure  2C ). In agreement with these findings and our previously published data, 27 the basicity of peptides was consistent with their ability to bind the α M I-domain; the positively charged peptides exhibited the highest affinity for the α M I-domain, whereas neutral peptides had lower affinity. Negatively charged peptides were not active. Furthermore, the role of hydrophobic residues is illustrated by the finding that only simultaneous mutation of basic and hydrophobic residues in peptides constituting the γC library ablated α M I-domain binding. 27
Identification of the α M I-Domain Recognition Motif (IRM)
Apart from being enriched with basic and hydrophobic residues, the α M I-domain binders displayed significant variability in amino acid sequences with no obvious consensus motif. However, we noted that hydrophobic residues often existed in the immediate proximity of basic residues forming small cores composed of three to five residues. The nature of these clusters and the amino acids involved in α M I-domain binding were determined by computational analyses of 196 strong binders. A list of strong binders is given in Table S1 of the Supporting Information. As shown in Table 2 , the relative occurrence of various motifs in which hydrophobic residues surround basic residues was ~3.5-7.0-fold higher in the population of α M I-domain binding peptides than in nonbinding peptides. It is noteworthy that the α M I-domain binders contain uncommon combinations of amino acids in which basic residues are surrounded by one or two hydrophobic residues on both sides. For example, the occurrence of a rare motif HyHyBHyHy in which four hydrophobic residues flank basic residues on both sides (motif 10) was 6.2-fold higher in binders than in nonbinding peptides. Likewise, motif 9 (HyBHyHy) occurred 7 times more often in the population of strong binders than in nonbinding peptides. Even simple combinations such as BHy or HyB were ~5 times more frequent in the population of α M I-domain binders. Furthermore, strong binders often contained several short motifs. Analyses indicated that ~80% of all hydrophobic residues in the population were assembled into individual cores that were no more than two residues from basic residues. Hydrophobic residues were found more frequently at positions −1 and +1 than at positions −2 and +2 ( Figure 3 ). For example, Ile and Met occurred 3.2-and 5.8-fold more often, respectively, in the immediate neighborhood of basic residues than at the secondary positions. Specific positioning of hydrophobic residues within the cores was not detected with the exception of that of Met, which was abundant at the −1 position (Figure 3 ). The positioning of the small basic/hydrophobic cores within 9-mer peptides does not appear to be important. Although the population of strong binders was enriched with Tyr (1.2-fold), which occurred slightly more frequently at the −3 position, no other preferences for this residue were noted. These analyses suggest that the principal feature of the α M I-domain recognition motif (IRM) is a short sequence composed of a central basic residue surrounded by hydrophobic residues.
Identification of the α M I-Domain Binding Motif by Phage Display
We also determined the α M I-domain binding sequences by an independent approach.
Affinity panning of libraries of bacteriophages that display random peptide sequences at the N-terminus of protein pIII was used to characterize peptides that bind the α M I-domain.
Because peptides containing at least six residues are sufficient for efficient binding to the α M I-domain, we chose to pan the phage library that displays 7-mer peptides. The library was incubated with the immobilized α M I-domain, and the bound phage were isolated using elution with the P2-C peptide. This approach is based on the finding that P2-C inhibits binding of the α M I-domain not only to fibrinogen (from which this peptide is derived) but also to many other ligands. After the three rounds of panning, the sequences of the inset of 26 clones were determined. Sequencing data demonstrated that six clones contained the ARLPIWF sequence, two clones contained ARLPLLW, two contained SMKPLWT, and one contained GRLPMPW, all of which resemble the most abundant ARLPIWF motif. Although there were no other apparent consensus sequences, seven clones with affinity for the α M Idomain contained the sequences in which Arg and Lys were flanked by hydrophobic residues (LTMPMIR, MAPHVRS, AATKLAF, LEPFFHR, SFRXVSP, AKQPFFW, and APHQXRS). The remaining clones contained no basic residues but were enriched with hydrophobic amino acids, especially Leu and Phe (data not shown). Only one Glu and one Asp were detected among 26 sequences. The sequences of inserts derived from phages eluted from PVA were enriched with Ser, Thr, and Gln and had no similarity. PVA is typically used as a postcoat in solid-phase binding assays with the α M I-domain and adhesion assays with α M β 2 -expressing cells. These analyses indicate that the sequences revealed by phage display conform to the IRM pattern determined in the analyses of strong binders from peptide libraries.
Development of the Algorithm Predicting α M I-Domain Binding Sites
To further analyze the substrate binding preferences of α M β 2 , we developed the α M I-domain recognition motif algorithm (IRMA), which allows the prediction of α M I-domain binding sites in naturally occurring protein sequences and synthetic peptides. The IRMA is based on scoring the statistical energy contributions of each amino acid in the nine residues constituting the proposed α M I-domain binding motif. The segment composed of nine residues was chosen arbitrarily, but its size is justified by findings that continuous stretches of that length are enriched in small cores composed of basic and hydrophobic residues and that their composition deviates significantly from that of the total library ( Table 2) . Although 6-mer peptides have the potential to bind the α M I-domain, this ability is realized only if they do not contain acidic residues. In contrast, 9-mer peptides can bind the α M Idomain even if they contain acidic residues, although as a rule the presence of each acidic residue needs to be compensated by an additional basic residue. The energy values were derived from the fold difference in the overall occurrence of each residue within strong binders and nonbinding peptides (Table S2 of the Supporting Information). We then wrote a computer program to calculate the combined energy value for any sequence present in the nanopeptides. This value serves as a measure of probability that the α M I-domain binds this sequence: the lower the energy, the higher the likelihood that the sequence binds the α M Idomain. As shown in Figure 4 , the energy values obtained for most of the population of strong binders ranged from −18 to +2, and those for the general population of nonbinding peptides ranged from −2 to +20. A small population of peptides (~1%) displayed energy values that were either below or above these limits. The energy distribution within a pool of good binders (range from −8 to +8) fell between these two groups ( Figure S2 of the Supporting Information). On the basis of these data, correct prediction is difficult for peptides with energy values between −2 and +8, but outside of this "gray area", the ability to predict that a peptide binds (or does not bind) the α M I-domain is high.
To test the quality of the IRMA, we determined the energy distribution within peptide libraries covering the sequences of α M β 2 ligands and compared them with experimental data. Within protein sequences, the algorithm scans for the energy minima that represent the regions with the highest probability of α M I-domain binding. As shown in Figure 5 for the γC domain of fibrinogen, there was an excellent correlation between the energy minima and the experimentally found α M I-domain binding sites. 27 It is noteworthy that several overlapping peptides encompassing the P2 sequence (spots 76-82) had the lowest energy values. Likewise, the strongest cluster in the scan of CCN1 [spots 91-96 ( Figure 1A) ] contains the peptide 305 SSVKKYRPKYCGS 317 , a previously identified binding site for α M β 2 , 25 and had the lowest energy value. Similar relationships were obtained for all ligands tested, suggesting that a length of nine residues is optimal for predicting the majority of sites.
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Localization of the α M I-Domain Binding Sequences within Native Protein Structures
To determine the localization of identified α M I-domain binding sequences within native folded protein structures, we mapped the sequences onto the corresponding threedimensional structures of neutrophil cationic proteins (see Table 1 for the PDB entries).
Only continuous stretches composed of several strong binders were analyzed. α M I-domain binding sequences were found in segments representing different secondary structure elements, with a slightly higher frequency of occurrence in the exposed loops (52% of segments analyzed) than in α-helices (20%) and β-strands (28%). These analyses suggest that the α M I-domain does not have strong preferences for specific structural motifs. Although some of the α M I-domain recognition segments were partially or completely buried within the protein cores, many side chains of critical basic and hydrophobic residues constituting the binding sites were well exposed (shown for cathepsin G in Figure S4 of the Supporting Information). It should be noted that the high percentage of α M I-domain binding sequences found in exposed loops might reflect the fact that the proteins included in the analyses are cationic proteins.
Peptides Derived from Peptide Libraries and Phage Display Inhibit α M I-Domain Binding
We next examined whether the α M I-domain binding peptides identified in the scans of various proteins and by phage display block α M I-domain binding. We also examined the relationship between the energy values of peptides predicted by the IRMA and their inhibitory activities. Selected 9-mer peptides corresponding to sequences derived from several proteins and covering a range of energy values were synthesized by traditional Fmoc chemistry and tested in solid-phase binding assays (Table 3 ). In addition, two 7-mer peptides revealed by phage display, ARLPIWF and GRLPMPW, were synthesized. Many of the selected peptides inhibited α M I-domain binding in a dose-dependent manner. As shown in Table 3 , their inhibitory activities varied widely with the highest potency (i.e., lowest IC 50 values) observed for peptides with the lowest calculated energy values. The peptide RKLRSLWRR (MP-9) derived from myeloperoxidase (21.3 kJ/mol) was the most potent and, on a molar basis, ~12-fold more active than P2-C. 24, 27 A strong relationship between the peptides' activities and their calculated energy scores was observed for the group of peptides with energy values in the range of approximately −20 to approximately −7 kJ/mol ( Figure S3 of the Supporting Information). As expected, the peptides with higher energy scores were weak inhibitors (Table 3 and Figure S3 of the Supporting Information) and no significant correlation between the peptides' activities and their energy scores was noted. The difference between the two groups of peptides showing a biphasic character of the relationship between inhibitory potencies and energy scores remains to be determined. The peptides that displayed positive energy values were inactive.
To corroborate studies with isolated α M I-domains using whole receptors, we tested myeloperoxidase-derived peptide MP-9 for its ability to block adhesion of α M β 2 -expressing cells. The peptide inhibited adhesion in a dose-dependent manner with IC 50 values of ~10 and 3.5 μM for α M β 2 -expressing HEK293 and U937 monocytic cells, respectively. On a molar basis, MP-9 was an ~4-fold more potent inhibitor of U937 cell adhesion than P2-C. MP-9 also directly supported strong cell adhesion (data not shown).
Binding of the α M I-Domain to Cationic Antimicrobial Peptides
The cationic nature of host defense peptides and the abundance of hydrophobic residues in their highly variable sequences suggest that they may contain α M I-domain binding sites. To investigate this possibility, we applied the developed algorithm to search the Antimicrobial Peptide Database (http://aps.unmc.edu/AP/main.html). The search revealed that numerous antimicrobial peptides, especially those with a net positive charge of >5, contain multiple IRMs. To confirm that these molecules interact with the α M I-domain, we synthesized peptide libraries covering the sequences of selected mammalian and non-mammalian host defense peptides, including human cathelicidin peptide LL-37, HNP-1, hBD-1, bovine bactenecin 5, fruit fly drosocin, pig tripticin, horseshoe crab polyphemusin, and the synthetic derivative IDR-1 (innate defense regulator) ( Table 1 ). Figure 1B provides examples of selected peptides and shows that they all interacted with the α M I-domain at multiple sites.
Notably, many peptides, such as LL-37 and bactenecin 5, contained long uninterrupted stretches of α M I-domain binding sequences.
The Human Cathelicidin LL-37 Peptide Induces α M β 2 -Mediated Responses in Monocytes
We next examined the ability of cationic host defense peptides to bind the receptor using the human cathelicidin peptide LL-37 ( Figure 6A ), an important host defense peptide that is produced by phagocytic and epithelial cells. 35 The protective effect of LL-37 seen in vivo 36 has been ascribed to its immunomodulatory properties, including the ability to induce a chemotactic response, release of cytokines, gene expression, and activation of intracellular signaling in human monocytes (reviewed in refs 37 and 38). We analyzed whether any of these responses are mediated by α M β 2 . As shown in Figure 6B , LL-37 induced a chemotactic response in U937 monocytic cells that was inhibited by the function-blocking anti-α M mAb 44a. LL-37 also induced migration of α M β 2 -expressing HEK293 cells in a Transwell system ( Figure 6C ). This response was dependent on LL-37 concentration, occurred at low (0.1-2 μg/mL) LL-37 concentrations ( Figure 6D ), and was inhibited by function-blocking anti-α M mAb 44a and anti-β 2 mAb IB4 but not by nonblocking anti-α M mAb OKM1 ( Figure 6C ). LL-37 did not induce migration of macrophages isolated from α M β 2 -deficient mice, suggesting that the loss of α M β 2 is specific for the function of LL-37 ( Figure 6E ). As a control, α M β 2 -deficient macrophages migrated to fMLP. The ability of LL-37 to induce α M β 2 -mediated cell migration is reminiscent of that of the P2-C peptide, which duplicates the binding site for α M β 2 in fibrinogen. 26 It is noteworthy though that LL-37 is the first naturally occurring bioactive peptide shown to bind α M β 2 .
To investigate the possibility that LL-37 is capable of inducing an activated state of α M β 2 ,
we assessed the reactivity of LL-37-treated neutrophils with mAb CBRM1/5, which specifically recognizes an activation-dependent epitope in the α M I-domain. 39 As shown in Figure 6F , LL-37 induced expression of the CBRM1/5 epitope in a concentration-dependent manner. The number of cells expressing the activation epitope induced by 10 μg/mL LL-37 was slightly higher than that stimulated by fMLP. When neutrophils were first incubated with the neutrophil inhibitory factor (NIF), a specific inhibitor that blocks ligand binding to the α M I-domain, and then treated with LL-37, no binding of CBRM1/5 was detected ( Figure  6F ). These data indicate that binding of LL-37 to α M β 2 induces receptor activation and initiates leukocyte migration. Second, acidic residues are strongly disfavored. Third, hydrophobic residues occur more frequently in the immediate neighborhood of basic residues, i.e., at the −1 and +1 positions, than at the −2 and +2 positions. Fourth, the presence of several basic residues in the 9-mer strongly increases the likelihood of α M I-domain binding. Fifth, the absence (or strong depletion) of acidic and hydrophilic residues in the regions flanking the 9-mer recognition sequence increases its probability of serving as an α M I-domain binding site. Thus, the α M Idomain recognition motif is a relatively small segment and has a high degree of redundancy in the hydrophobic residues that surround critical basic residues. These characteristics are consistent with the capacity of α M β 2 to recognize a wide variety of unrelated sequences and thus form the basis for α M β 2 ligand binding promiscuity.
The finding that the presence of basic and hydrophobic amino acids is an important feature of the α M I-domain binding peptides supports and extends our earlier studies with fibrinogen 24, 27 and CCN1 25 as well as the localization of α M β 2 recognition sequences reported in other studies. For example, the identification of the α M I-domain recognition motif explains the ability of α M β 2 to bind LYQAKRFKV or SSVKKYRPKYCGS, the peptides derived from Factor X. 40 Although the α M β 2 binding nanopeptide CPCFLLGCC (LLG-C4) derived from phage display 41 does not contain basic residues, the presence of a Phe-Leu-Leu hydrophobic core may account for its capacity to interact with α M β 2 . It is interesting that several negatively charged peptides tested in our scans (1.8%) bound the α M I-domain and were anomalously enriched with Leu (2.6-fold) and Trp (3.7-fold). However, LLG-C4 was also shown to interact with the monospecific integrin α L β 2 , whereas typical α M β 2 ligands, such as P2-C (γTMKIIPFFNRLTIG), do not. 5 Therefore, the presence of basic residues appears to endow the peptide sequences with recognition activity toward α M β 2 . Although Ile, Leu, Phe, Val, and Met are enriched in the α M I-domain binding peptides, no apparent dominant hydrophobic residues were identified and no specific positioning of hydrophobic residues (except for methionine at the −1 position) has been noted ( Figures 2B and 3) . However, we cannot exclude the possibility that some hydrophobic residues are more important than others, and further studies of their contribution, as well as that of aromatic residues, are needed to dissect structural features of the α M I-domain recognition motif.
The nature of the α M I-domain recognition motif (IRM) explains why the capacity of α M β 2 to bind proteins increases dramatically after their chemical or thermal denaturation 4 or after their unfolding as a consequence of adsorption to plastic surfaces: 4, 42 the IRMs are rich in hydrophobic residues whose side chains are normally buried in the interior of folded proteins, and protein unfolding results in the exposure of such sequences. This behavior is exemplified by P2-C, which is part of the β-sheet in the γC domain of fibrinogen. This sequence is hidden in the soluble intact protein but becomes unmasked as a result of its unfolding upon adsorption onto various surfaces or during deposition in the extracellular matrix. 42, 43 The masking of potential α M I-domain binding sites in the interior of folded proteins could, at least in part, explain the observation that many intact soluble ligands bind poorly to α M β 2 -expressing cells in suspension but support efficient adhesion when presented to the receptor in an immobilized form.
The recognition specificity of the α M I-domain is remarkably reminiscent of that of molecular chaperones, especially those belonging to the Hsp70 family. 28, 44 This finding supports the original proposal by Davies 4 that α M β 2 's ability to bind unfolded proteins shares similarities with that of chaperones. Molecular chaperones represent one of several biological systems in which promiscuity in ligand binding plays important roles. Chaperones assist in protein folding in the cell by transient association with a large variety of short hydrophobic sequences that are generally accessible only in non-native conformers. Although differences exist with respect to the positioning of basic residues within the hydrophobic patch, the general requirements regarding size, the presence of basic and hydrophobic residues, and the exclusion of negatively charged residues appear to be comparable for the α M I-domain and chaperone sequences. It is noteworthy that NRLLLTG, a classic chaperone peptide 45, 46 binds the α M I-domain (Table 3 ) and inhibits α M β 2 -mediated cell adhesion. The basis for this activity is likely to be the presence of Arg and adjacent leucines at the +1 and +2 positions. Notably, NRLLLTG closely resembles γ 390 NRLTIG 395 , the α M I-domain recognition motif within P2-C, 24, 34 which has been confirmed as the α M β 2 binding site in fibrinogen by genetic manipulation in mice. 47, 48 The overlap in recognition specificity between α M β 2 and chaperons is not entirely unexpected because both proteins prefer unfolded conformers as their substrates. However, they are involved in opposite processes: while chaperones recognize peptide sequences to ensure their correct folding, the α M I-domain binds to sequences that are exposed in denatured unfolded conformers.
The characteristics of IRM also explain why many neutrophil cationic proteins, including elastase, myeloperoxidase, and azurocidin, are α M β 2 ligands. As illustrated here for cathepsin G ( Figure S4 of the Supporting Information), the side chains of many critical basic and adjacent hydrophobic residues within the α M I-domain binding clusters are exposed on the surface of these proteins, which probably explains why these proteins bind α M β 2 even when presented to the receptor in soluble form. Indeed, free myeloperoxidase released from stimulated neutrophils during inflammation binds neutrophils through an α M β 2 -dependent mechanism. 49 We propose that other cationic proteins that are normally sequestered in granules of resting neutrophils can also bind α M β 2 after their release upon cell activation.
Our analyses of the α M I-domain binding preferences allowed us to develop an algorithm that predicts the α M I-domain binding sites in α M β 2 ligands with a high degree of accuracy.
This information, in conjunction with the crystal structure when available, may be useful for the prediction of sequences that are displayed on the surface of proteins and potentially serve as α M I-domain binding sites. The algorithm also appears to be reliable in predicting the potency of α M I-domain binding peptides. Its application has already uncovered several peptides with affinities for the α M I-domain several-fold higher than that previously reported for fibrinogen peptide P2-C (Table 3 ). This could be important in the search for antagonists because in vivo modulation of α M β 2 can be effective in limiting inflammatory injury (reviewed in ref 50) . Finally, application of the algorithm to search the Antimicrobial Peptide Database 51 revealed that numerous mammalian and non-mammalian cationic peptides contain α M I-domain recognition patterns and can potentially bind α M β 2 ( Figure   1B ). The prediction that one of the host defense peptides, human cathelicidin LL-37, binds α M β 2 was confirmed experimentally.
Previous studies have demonstrated that LL-37 triggers migration of neutrophils and monocytes and induces activation of MAP kinases, production of chemokines, gene expression, and degranulation of mast cells (reviewed in refs 37 and 38). The finding that LL-37 contains multiple α M I-domain binding sites provides new insights into the mechanisms by which LL-37 may elicit numerous immunomodulatory responses. The mechanism by which LL-37 exerts leukocyte-modulating effects has been controversial. Although the direct chemotactic activity of LL-37 was attributed to G-protein-coupled fMLP-like receptor 1, 52 many other responses induced by this peptide in monocytes are independent of G-protein-coupled receptors. 38 The finding that migration of U937 monocytic cells in response to LL-37 is blocked by α M β 2 reagents ( Figure 6 ) indicates that α M β 2 is the LL-37 receptor that triggers a migratory signal in these cells.
The α M β 2 binding specificity revealed in this study may have broad biological implications and provides a basis for new investigations into the biology of this integrin. First, because of its central role in neutrophil and macrophage biology and its significance as a validated therapeutic target for inflammatory diseases, α M β 2 is the subject of intensive research. As a result, the list of α M β 2 ligands grows every year and may include many biologically irrelevant molecules. The nature of the α M I-domain recognition motif suggests that the extensive collection of α M β 2 ligands might simply reflect the receptor's potential to bind sequences exposed by protein denaturation. Immobilization of proteins on plastic surfaces, which represents a standard method for testing a protein's capacity to serve as a potential integrin's ligand, inevitably leads to protein unfolding and unmasking of the α M I-domain binding segments that are normally buried inside the protein's three-dimensional structure. Our findings suggest that some of the ligands that have been identified on the basis of their ability to support α M β 2 -mediated adhesion may need to be re-evaluated in terms of their physiological relevance.
Second, the identification of the α M I-domain recognition motif may help to identify new molecules that repel α M β 2 and thus render surfaces antiadhesive for phagocytic leukocytes, an important biomaterial application. Third, because many integrins exhibit promiscuity in ligand binding, it will be interesting to determine whether the principles governing α M β 2 ligand promiscuity are shared by other members of the integrin family. Fourth, the connection between the α M I-domain and chaperones is intriguing. Although the similarities in recognition specificity displayed by both molecules endow them with the ability to recognize diverse ligands, how these recognition principles evolved is unknown.
Finally, the nature of the α M I-domain recognition motif suggests that α M β 2 ligands may serve as alarm/danger signals. It has been proposed that proteins released by damaged or dead cells alarm the immune system. 53, 54 The original "danger" model postulated that segments of proteins that are initially buried inside the folded molecules, especially their hydrophobic portions, would function as alarm signals upon being exposed. 53 Consequently, if a cell is disrupted, the hydrophobic sequences of nascent proteins synthesized on ribosomes, which are normally bound to chaperones, will be exposed. The characteristics of the α M I-domain recognition sequences with their abundance of hydrophobic and positively charged residues, their resemblance to the segments recognized by chaperones, and an enormous diversity of α M I-domain binding sequences are consistent with the idea that α M β 2
is an alarm/danger-sensing molecule, or the so-called "alarmin" receptor. The term alarmin was initially coined to include activities of cathelicidin LL-37, defensins, HMGB 1, and eosinophil-derived neurotoxin (EDN), which, despite their diverse structures, all have chemotactic and activating effects on leukocytes. 55 Moreover, the three of these are α M β 2 ligands ( Figure 1 and ref 13 ). As an extension of the "alarm/danger" model, we propose that neutrophil cationic proteins and peptides that are sequestered in granules of resting neutrophils and secreted during the immune-inflammatory response would also qualify as alarmins. Indeed, myeloperoxidase activates neutrophils via α M β 2 -dependent MAPK activation, 49 and azurocidin induces Ca 2+ mobilization in monocytes via β 2 integrins, most likely α M β 2 . 56 Thus, it is reasonable to assume that any intracellular molecule that carries the IRMs and is released from damaged cells during tissue injury might be an alarmin that signals through the α M β 2 receptor. The recently reported HMGN1 (high-mobility nucleosome binding protein 1) is an alarmin 57 and also a potential α M β 2 ligand ( Figure S5 of the Supporting Information). Although several receptors have been implicated in triggering alarmin responses in leukocytes, 55 α M β 2 is the first molecule for which a common recognition pattern present in a large and diverse group of alarmin molecules has been identified.
In summary, we have revealed the molecular basis for the broad ligand specificity exhibited by integrin α M β 2 , solving the long-standing puzzle of why ligand binding by this receptor is driven by protein denaturation. Furthermore, the elucidation of recognition specificity of α M β 2 led to several conjectures. The prediction that the host defense peptide LL-37, which harbors several IRMs, triggers immunomodulatory responses via α M β 2 has been confirmed experimentally. Another proposal, based partly on experimental evidence ( Figure 1B) , predicts that host defense peptides constitute a new class of α M β 2 ligands. The newly solved α M I-domain recognition motif could be used to identify molecules that are induced in injured tissues and might act as alarmins through activation of α M β 2 . Table 1) that represent the entire library (gray bars) compared with that in protein sequences derived from the protein databases 58, 59 (black bars). The frequency of each amino acid in the group of strong α M I-domain binders (B) and nonbinding peptides (C) was calculated as a percentage of its occurrence in the whole peptide library (100%, dashed line). The data for each amino acid in strong binding and nonbinding peptides were obtained for each protein shown in Table 1 and presented as means ± the standard deviation. P values are given for Frequency of hydrophobic residues at the specified positions around basic residues in the population of strong α M I-domain binders. The relative occurrence of hydrophobic residues at the −2, −1, +1, and +2 positions around basic residues (Arg or Lys; set as "0") in the population of strong α M I-domain binders (196 peptides) is given as a percentage. Although
Pro was slightly depleted in the population, it was frequently found in the vicinity of basic residues and, therefore, was included in the analyses. The small hydrophobic amino acid Ala is not included. Biochemistry. Author manuscript; available in PMC 2015 August 11.
